Showing 1,141 - 1,160 results of 122,698 for search '(( 2 e decrease ) OR ( 5 ((step decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.25s Refine Results
  1. 1141
  2. 1142

    (A) The proportion of fast MyHC myotubes is decreased in Igf-2 deficient mice (maternal disomy Chromosome 7 - MatDi) at E14 by Deborah Merrick (54928)

    Published 2011
    “…(B) Embryo immunoblotting for Igf-2 demonstrates a stage related increase in Igf-2 protein between E10.5 and E15.5 in WT and absence of Igf-2 in MatDi embryos at E14.5 and E15.5 Tracks 1–4 E10.5, E13.5, E14.5 and E15.5 WT embryos respectively, Track 5 E14.5 MatDi, Track 6 E15.5 MatDi and Track 7 E15.5 WT. …”
  3. 1143
  4. 1144
  5. 1145

    VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

    Published 2018
    “…<b>(D)</b> HR [hazard ratio] of 1.72, p<1x10<sup>-16</sup>). <b>(E)</b> Similar analysis of 2,061 patients with ER<sup>+</sup> breast cancer (HR 1.48, p = 5.5x10<sup>-6</sup>). …”
  6. 1146
  7. 1147

    Ibuprofen and diclofenac decrease proliferation. by Verena Leidgens (815986)

    Published 2015
    “…<p>Proliferation was analyzed using crystal violet staining and results were verified via the CyQuant Direct Cell Proliferation assay in HTZ-349. (A) Starting at 72 h, all ibuprofen concentrations (0.5, 1, 2 mM) resulted in significant reduction of HTZ-349 proliferation (compared to non-treated Ctrl, 95% CI, p < 0.05). 2 mM ibuprofen caused significant proliferation inhibition at 24 h (0.01 > p ≤ 0.001) and 48 h (p < 0.0001). …”
  8. 1148
  9. 1149

    Forbush Decrease Catalog at MESSENGER by Emma Davies (12046748)

    Published 2022
    “…<p>For each Forbush decrease (Fd) identified, we list the associated ICME boundary times i.e. the ICME start, magnetic ejecta (ME) start, and the ICME end times in ISO standard. …”
  10. 1150
  11. 1151

    WT1 siRNA decreases proliferation, pAKT, and Bcl2 expression. by Ayana E. Morales (17756335)

    Published 2024
    “…</b> RT-qPCR of WT1, p<0.05(*), vFLIP(ns), LANA, p<0.0001(****), K8.1, p<0.0001(****), and BCL2 p<0.05(*) in the setting of WT1 knockdown in ISLK BAC-16 with WT1 siRNA in comparison to a control siRNA using two-sided, unpaired student’s t-tests. …”
  12. 1152
  13. 1153

    Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…<p>In the recurrence group, mean outpatient visits (± standard deviation) decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
  14. 1154
  15. 1155
  16. 1156
  17. 1157

    Parvalbumin-positive interneurons (PV-INs) in perilesional tissue respond to optogenetic stimulation and are involved in voluntary movement, but show a decreased firing rate. by Livia Vignozzi (22430567)

    Published 2025
    “…Data are shown as mean ± SEM. Created in BioRender. Vignozzi, L. (2025) <a href="https://BioRender.com/md8zh2c" target="_blank">https://BioRender.com/md8zh2c</a>. …”
  18. 1158
  19. 1159

    CII, inhibitor of SphK, decreases both the migration of HPAECs in a scratch assay <i>in vitro</i> and the content of S1P in HPAECs. by Evgeny V. Berdyshev (307465)

    Published 2013
    “…<p>HPAECs grown to ∼95% confluence in 35 mm dishes were starved for 3 h in 0.1% FBS in EBM-2 without growth factors and treated with 10 µM of CII. …”
  20. 1160